Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience
- Lorusso, Roberto
- Centofanti, Paolo
- Gelsomino, Sandro
- Barili, Fabio
- Di Mauro, Michele
- Orlando, Parise
- Botta, Luca
- Milazzo, Filippo
- Actis Dato, Guglielmo
- Casabona, Riccardo
- Casali, Giovanni
- Musumeci, Francesco
- De Bonis, Michele
- Zangrillo, Alberto
- Alfieri, Ottavio
- Pellegrini, Carlo
- Mazzola, Sandro
- Coletti, Giuseppe
- Vizzardi, Enrico
- Bianco, Roberto
- Gerosa, Gino
- Massetti, Massimo
- Caldaroni, Federica
- Pilato, Emanuele
- Pacini, Davide
- Di Bartolomeo, Roberto
- Marinelli, Giuseppe
- Sponga, Sandro
- Livi, Ugolino
- Mauro, Rinaldi
- Mariscalco, Giovanni
- Beghi, Cesare
- Miceli, Antonio
- Glauber, Mattia
- Pappalardo, Federico
- Russo, Claudio Francesco
DOIAbstract
Acute fulminant myocarditis (AFM) may represent a life-threatening event, characterized by rapidly progressive cardiac compromise that ultimately leads to refractory cardiogenic shock or cardiac arrest. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) provides effective cardiocirculatory support in this circumstance, but few clinical series are available about early and long-term results. Data from a multicenter study group are reported which analyzed subjects affected by AFM and treated with VA-ECMO during a 5-year period
Add to ORKG